Green Therapeutics

Australis Capital Inc. (OTCQB: AUSAF) (CSE:AUSA) released its unaudited results for its fiscal year ended March 31, 2022, revealing revenue increased by over 1,200% to nearly CA$9.5 million ($7.38 million), driven predominantly by a full year of ALPS revenue consolidated, as well as growth in the...

Australis Capital Inc. (OTC: AUSAF) announced its latest corporate update on Tuesday, detailing branding shifts and continued expansion efforts. Name Change The update included a name change for the company's U.S. adult-use operations. Now operating as Audacious Brands, the company plans to...